Christina Rossi - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Christina Rossi has filed 1 SEC Form 4 filing across 1 company in the last 90 days - selling. Lifetime open-market sales: $585K.
Profile
Christina Rossi is a corporate insider at CG Oncology, Inc. (CGON). Rossi's filing history also covers Blueprint Medicines Corp (BPMC). Rossi has reported 8 insider filings with the SEC since 2024. The most recent filing was in June 2026.
| Role | Insider |
|---|---|
| Notability | 34/100 |
Board memberships
- CG Oncology, Inc.
- Blueprint Medicines Corp
Reported roles
- Chief Operating Officer
Trading Pattern
InsiderAlpha's records for Christina Rossi go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. 4 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Career & Filing History
Every role Christina Rossi has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Insider at CG Oncology, Inc. (CGON) - 2 filings, 2025 to 2026
- Chief Operating Officer at Blueprint Medicines Corp (BPMC) - 1 filing, 2025
- CHIEF OPERATING OFFICER at Blueprint Medicines Corp (BPMC) - 3 filings, 2024 to 2025
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-07-17 | BPMC | Blueprint Medicines Corp | J - Other acquisition / disposition | 20.6K | - | |
| 2025-07-17 | BPMC | Blueprint Medicines Corp | D - Derivative transaction | 82.4K | - | |
| 2025-07-17 | BPMC | Blueprint Medicines Corp | A - Grant or award | 39.5K | - | |
| 2025-07-03 | BPMC | Blueprint Medicines Corp | S - Open-market sale | 1.2K | $128.25 | $150K |
| 2024-12-20 | BPMC | Blueprint Medicines Corp | S - Open-market sale [10b5-1] | 108 | $96.50 | $10K |
| 2024-12-20 | BPMC | Blueprint Medicines Corp | S - Open-market sale [10b5-1] | 2.2K | $95.88 | $208K |
| 2024-12-02 | BPMC | Blueprint Medicines Corp | S - Open-market sale [10b5-1] | 2.3K | $95.10 | $216K |
Companies - Last 90 Days
- CG Oncology, Inc. (CGON) - 1 filing, last 2026-06-05
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Christina Rossi has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Brian Guan-Chyun Liu - $74.81M of CGON open-market activity in the last 12 months
- James Mulay - $6.28M of CGON open-market activity in the last 12 months
- Hong Fang Song - $2.78M of CGON open-market activity in the last 12 months
- Leonard E. Post - $1.15M of CGON open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Jonathan H. Cohen
- Ryan Cohen
- Charles K. Cohn
- Coliseum Capital Management, LLC
- Column Group IV GP, LP
- Connect Midstream, LLC
- CONSTELLATION SOFTWARE INC
- Lisa A. Conte
Frequently Asked Questions
Who is Christina Rossi?
Christina Rossi is a corporate insider at CG Oncology, Inc. (CGON). Rossi's filing history also covers Blueprint Medicines Corp (BPMC). Rossi has reported 8 insider filings with the SEC since 2024. The most recent filing was in June 2026.…
How many SEC Form 4 filings has Christina Rossi submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Christina Rossi been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($585K) across all tracked filings.
Where can I see all of Christina Rossi's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Christina Rossi profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.